Advisors to the CDC unanimously recommended Novavax’s COVID-19 vaccine, claiming the unvaxxed are the product’s “primary target population.”
A FOI request made to Australia’s drug regulator has revealed they have never seen the extremely limited study data for the Pfizer/BioNTech vaccine.